Earth Science Tech Inc - Understand $etst stock

$ETST Market Cap: $37.09 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$26.89M

TTM

Gross Margin

69.9%

TTM

Net Earnings

$2.332M

TTM

Current Assets

$2.281M

Q3 2024

Current Liabilities

$1.699M

Q3 2024

Current Ratio

134.24%

Q3 2024

Total Assets

$5.050M

Q3 2024

Total Liabilities

$1.848M

Q3 2024

Book Value

$3.201M

Q3 2024

Cash

$1.532M

Q3 2024

P/E

15.90

Nov 14, 2024 EST

Free Cash Flow

$1.680M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	$11.95M	$48.54K	$14.12K	$140.9K	$526.1K	$770.6K	$463.1K	$452.2K	$469.5K	$80.28K	$10.00K	$40.00K	$20.00K	$0.00
YoY Change	24527.88%	243.67%	-89.98%	-73.22%	-31.73%	66.41%	2.42%	-3.68%	484.77%	702.8%	-75.0%	100.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	$11.95M	$48.54K	$14.12K	$140.9K	$526.1K	$770.6K	$463.1K	$452.2K	$469.5K	$80.28K	$10.00K	$40.00K	$20.00K	$0.00
Cost Of Revenue	$4.125M	$26.48K	$22.64K	$101.0K	$307.7K	$475.6K	$270.2K	$223.2K	$341.9K	$77.06K	$0.00	$10.00K	$0.00	$0.00
Gross Profit	$7.828M	$22.06K	-$8.516K	$39.93K	$218.5K	$295.0K	$192.9K	$229.0K	$127.5K	$3.220K	$10.00K	$40.00K	$20.00K	$0.00
Gross Profit Margin	65.49%	45.45%	-60.3%	28.34%	41.52%	38.28%	41.65%	50.64%	27.17%	4.01%	100.0%	100.0%	100.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Selling, General & Admin	$167.0K	$240.0K	$119.7K	$228.8K	$966.2K	$1.608M	$1.576M	$1.287M	$785.3K	$8.737M	$12.55M	$100.0K	$20.00K	$20.00K
YoY Change	-30.42%	100.44%	-47.67%	-76.32%	-39.92%	2.06%	22.38%	63.95%	-91.01%	-30.38%	12450.0%	400.0%	0.0%
% of Gross Profit	2.13%	1087.78%		572.92%	442.23%	545.04%	816.82%	562.23%	615.71%	271327.95%	125500.0%	250.0%	100.0%
Research & Development		$0.00		$9.000K	$76.11K	$338.9K	$150.5K	$0.00		$32.59K		$0.00	$20.00K
YoY Change				-88.18%	-77.54%	125.23%						-100.0%
% of Gross Profit		0.0%		22.54%	34.84%	114.86%	78.0%	0.0%		1012.11%		0.0%	100.0%
Depreciation & Amortization	$34.38K	$6.869K	$0.00	$2.421K	$7.230K	$11.53K	$23.53K	$12.44K	$13.16K	$4.480K
YoY Change	400.52%		-100.0%	-66.51%	-37.29%	-51.0%	89.15%	-5.47%	193.75%
% of Gross Profit	0.44%	31.14%		6.06%	3.31%	3.91%	12.2%	5.43%	10.32%	139.13%
Operating Expenses	$6.936M	$972.6K	$218.2K	$4.342M	$1.042M	$1.947M	$1.762M	$1.287M	$785.3K	$8.769M	$12.55M	$90.00K	$50.00K	$20.00K
YoY Change	613.15%	345.76%	-94.97%	316.6%	-46.46%	10.52%	36.82%	63.94%	-91.05%	-30.12%	13844.44%	80.0%	150.0%
Operating Profit	$892.3K	-$950.5K	-$226.7K	-$4.302M	-$823.8K	-$1.652M	-$1.569M	-$1.058M	-$657.8K	-$8.766M	-$12.54M	-$50.00K	-$30.00K	-$20.00K
YoY Change	-193.88%	319.28%	-94.73%	422.23%	-50.13%	5.3%	48.2%	60.92%	-92.5%	-30.09%	24980.0%	66.67%	50.0%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Interest Expense	$67.21K	$47.43K	$10.90K	$4.765K	-$318.0K	-$75.63K	-$4.770K	-$2.390K	-$4.730K	-$4.610K	$0.00	$0.00	$0.00
YoY Change	41.69%	335.13%	128.77%	-101.5%	320.52%	1485.53%	99.58%	-49.47%	2.6%
% of Operating Profit	7.53%
Other Income/Expense, Net	-$67.21K	$571.3K	$3.400M	-$81.06K	$26.35K
YoY Change	-111.76%	-83.2%	-4294.43%	-407.62%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Pretax Income	$825.1K	-$379.3K	$3.173M	-$4.383M	-$1.200M	-$2.215M	-$1.714M	-$1.099M	-$1.223M	-$8.771M	-$12.54M	-$60.00K	-$20.00K	-$20.00K
YoY Change	-317.56%	-111.95%	-172.4%	265.19%	-45.82%	29.28%	55.87%	-10.1%	-86.06%	-30.06%	20800.0%	200.0%	0.0%
Income Tax	$13.00K		$0.00	$0.00	$0.00			$0.00	$0.00	$0.00		$0.00	$0.00	$0.00
% Of Pretax Income	1.58%		0.0%
Net Earnings	$812.1K	-$379.3K	$3.173M	-$4.383M	-$1.200M	-$2.215M	-$1.714M	-$1.099M	-$1.223M	-$8.771M	-$12.54M	-$60.00K	-$20.00K	-$20.00K
YoY Change	-314.13%	-111.95%	-172.4%	265.19%	-45.82%	29.28%	55.87%	-10.1%	-86.06%	-30.06%	20800.0%	200.0%	0.0%
Net Earnings / Revenue	6.79%	-781.4%	22468.74%	-3110.8%	-228.12%	-287.47%	-370.03%	-243.14%	-260.49%	-10925.19%	-125400.0%	-150.0%	-100.0%
Basic Earnings Per Share	$0.00	$0.00	$0.06	-$0.08
Diluted Earnings Per Share	$0.00	$0.00	$58.93K	-$86.14K	-$31.74K	-$42.44K	-$37.13K	-$26.10K	-$31.02K	-$238.1K	-$1.165M	-$6.322K	-$2.985K	-$479.60

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Cash & Short-Term Investments	$707.1K	$35.76K	$26.94K	$16.16K	$30.72K	$127.5K	$72.04K	$192.9K	$44.49K	$324.4K	$550.0K	$0.00	$10.00K	$0.00
YoY Change	1877.27%	32.74%	66.71%	-47.4%	-75.91%	77.01%	-62.66%	333.67%	-86.28%	-41.02%		-100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets			$0.00	$0.00	$50.00	$33.75K	$6.030K	$51.19K	$12.40K	$101.6K	$350.0K	$0.00	$0.00
YoY Change				-100.0%	-99.85%	459.7%	-88.22%	312.82%	-87.8%	-70.97%
Inventory	$315.7K	$10.26K	$0.00	$21.74K	$63.35K	$161.3K	$134.8K	$107.2K	$135.4K	$235.6K	$0.00
Prepaid Expenses
Receivables	$235.4K		$0.00	$6.110K	$38.93K	$70.93K	$69.05K							$0.00
Other Receivables	$0.00		$0.00	$0.00	$0.00	$0.00	$0.00							$0.00
Total Short-Term Assets	$1.258M	$46.02K	$26.94K	$44.01K	$133.1K	$393.5K	$281.9K	$351.3K	$192.3K	$661.6K	$900.0K	$0.00	$10.00K	$10.00K
YoY Change	2634.09%	70.82%	-38.79%	-66.92%	-66.19%	39.59%	-19.75%	82.72%	-70.94%	-26.49%		-100.0%	0.0%
Property, Plant & Equipment	$291.9K	$343.9K	$0.00	$14.37K	$15.30K	$11.36K	$18.49K	$60.57K	$68.46K	$83.07K	$0.00
YoY Change	-15.13%		-100.0%	-6.08%	34.68%	-38.56%	-69.47%	-11.52%	-17.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$25.00K	$6.190K	$6.190K	$6.190K	$6.190K	$17.21K	$23.83K
YoY Change			303.88%	0.0%	0.0%	0.0%	-64.03%	-27.78%
Total Long-Term Assets	$2.623M	$2.646M	$50.00K	$20.55K	$21.49K	$17.55K	$63.42K	$120.9K	$139.8K	$112.1K	$0.00	$0.00	$0.00	$0.00
YoY Change	-0.87%	5192.36%	143.31%	-4.37%	22.45%	-72.33%	-47.56%	-13.52%	24.7%
Total Assets	$3.881M	$2.692M	$76.94K	$64.56K	$154.6K	$411.1K	$345.3K	$472.2K	$332.1K	$773.7K	$900.0K	$0.00	$10.00K	$10.00K
YoY Change
Accounts Payable	$530.7K	$90.79K	$202.3K	$174.0K	$82.23K	$98.11K	$80.44K	$356.2K		$88.66K	$0.00	$20.00K	$20.00K	$20.00K
YoY Change	484.56%	-55.11%	16.25%	111.59%	-16.19%	21.97%	-77.42%				-100.0%	0.0%	0.0%
Accrued Expenses	$70.49K	$426.4K	$995.7K	$4.280M	$410.3K	$316.8K	$289.3K	$0.00	$223.5K		$0.00
YoY Change	-83.47%	-57.18%	-76.73%	943.0%	29.54%	9.49%		-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$682.5K	$637.8K	$487.5K	$202.9K	$59.56K	$59.56K	$59.56K	$59.56K	$40.00K	$30.00K	$30.00K	$0.00
YoY Change		-100.0%	7.0%	30.83%	140.31%	240.6%	0.0%	0.0%	0.0%	48.9%	33.33%	0.0%
Long-Term Debt Due	$30.59K	$604.8K
YoY Change	-94.94%
Total Short-Term Liabilities	$1.487M	$1.307M	$1.882M	$5.091M	$980.1K	$617.7K	$429.3K	$415.8K	$461.6K	$148.2K	$210.0K	$70.00K	$50.00K	$20.00K
YoY Change	13.71%	-30.55%	-63.03%	419.51%	58.65%	43.89%	3.26%	-9.92%	211.42%	-29.42%	200.0%	40.0%	150.0%
Long-Term Debt	$60.56K	$204.4K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-70.37%
Other Long-Term Liabilities	$84.95K	$96.74K
YoY Change	-12.19%
Total Long-Term Liabilities	$145.5K	$301.2K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-51.68%
Total Liabilities	$1.632M	$1.608M	$1.882M	$5.091M	$980.1K	$617.7K	$429.3K	$415.8K	$461.6K	$148.2K	$210.0K	$70.00K	$50.00K	$20.00K
YoY Change	1.47%	-14.55%	-63.03%	419.51%	58.65%	43.89%	3.26%	-9.92%	211.42%	-29.42%	200.0%	40.0%	150.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2024	2023	2022
Basic Shares Outstanding	309.7M shares	145.9M shares	53.85M shares
Diluted Shares Outstanding	309.7M shares	145.9M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $37.086 Million

About Earth Science Tech Inc

Earth Science Tech, Inc. is a holding company, which engages in research and development of pharmaceutical products. The company is headquartered in Miami, Florida and currently employs 32 full-time employees. The company went IPO on 2012-08-29. The firm is engaged in the compounding pharmaceuticals and telemedicine sectors, through its wholly owned subsidiaries, RxCompoundStore.com, LLC. (RxCompound), Peaks Curative, LLC. (Peaks), and Earth Science Foundation, Inc. (ESF). RxCompound is licensed to fulfill prescriptions in the states of Delaware, Florida, Pennsylvania, New York, Arizona, New Jersey, Wisconsin, Minnesota, Rhode Island, Utah, Georgia, Nevada, Massachusetts, Missouri, Iowa, Maryland, Ohio, Colorado, North Carolina, Maine, Indiana, and Illinois. Peaks is a telemedicine referral site focused on overall health and wellness for men and women. Peaks’ orders are exclusively fulfilled by RxCompound. Patients who order Peaks via monthly subscription receive their refills automatically. ESF accepts grants and donations to help those in need of assistance in paying for prescriptions.

Industry: Pharmaceutical Preparations Peers: Kaya Holdings Inc Clarus Therapeutics Holdings, Inc. CANNABIS STRATEGIC VENTURES Gelstat Corp Panacea Life Sciences Holdings Inc Johnson & Johnson